TNG-462, a novel MTA-cooperative PRMT5 inhibitor for cancer treatment
Aug. 21, 2023
Methylthioadenosine phosphorylase (MTAP) is an enzyme ubiquitously expressed in all tissues. MTAP homozygous deletion occurs in 10-15% of different cancers such as leukemia, lymphoma, lung, brain, breast and others.